← Back to Search

Hypoxia for Hypoxia

N/A
Waitlist Available
Led By Keith J Ruskin, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights
No Placebo-Only Group

Summary

The purpose of this study is to evaluate the effect of breathing a slightly reduced amount of oxygen will have on a rescuer's ability to provide chest compressions during CPR.

Eligible Conditions
  • Hypoxia
  • Cardiac Arrest

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Successful CPR
Secondary study objectives
Lowest oxygen saturation
Survey results - Chest compression
Survey results - Fatigue

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: HypoxiaExperimental Treatment1 Intervention
The reduced oxygen breathing device will be set to deliver a gas mixture with15% oxygen. (Equivalent to the partial pressure of oxygen at 2,438 meters.) The subject will perform CPR while breathing through mask and tubing that is connected to the device.
Group II: Room AirActive Control1 Intervention
The reduced oxygen breathing device will be set to deliver room air. (i.e., no oxygen is removed from the gas mixture. The subject will perform CPR while breathing through mask and tubing that is connected to the device.

Find a Location

Who is running the clinical trial?

University of ChicagoLead Sponsor
1,043 Previous Clinical Trials
758,488 Total Patients Enrolled
2 Trials studying Hypoxia
240 Patients Enrolled for Hypoxia
Keith J Ruskin, MDPrincipal InvestigatorUniversity of Chicago
~3 spots leftby Oct 2025